Drug or treatment

Filgotinib clinical trials

• 6Clinical trials
• 17Countries

Newest trials

All recruiting trials (6)

• Filgotinib for children with polyarticular juvenile idiopathic arthritis

  This study tests whether and how filgotinib works and is tolerated in children and adolescents with active polyarticular JIA over about 18 weeks.

  Recruiting at 14 sites Phase 3 Alfasigma S.p.A. · Leuven and 13 other locations · NCT07554495

• Open-label extension with filgotinib for juvenile idiopathic arthritis

  This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.

  Recruiting at 2 sites Phase 3 Alfasigma S.p.A. · Le Kremlin-Bicêtre and 3 other locations · NCT07553182

• Filgotinib for children and teenagers with ulcerative colitis

  This will test whether filgotinib helps children and teenagers (8 to under 18 years) with moderate-to-severe ulcerative colitis control their symptoms and reduce disease activity.

  Recruiting at 44 sites Phase 3 Alfasigma S.p.A. · Brussels, Brussels Capital and 45 other locations · NCT06865417

• Evaluating the safety and effectiveness of Jyseleca tablet in Korean patients

  This study is testing how safe and effective the Jyseleca tablet is for Korean patients with rheumatoid arthritis and ulcerative colitis who haven't found relief with other treatments.

  Recruiting at 57 sites Eisai Inc. · Cheonan, Chungcheongnam-do and 58 other locations · NCT06246123

• Using advanced MRI to understand how Filgotinib relieves pain in rheumatoid arthritis

  This study is testing how Filgotinib helps relieve pain in people with rheumatoid arthritis by looking at brain activity and inflammation.

  Recruiting NHS Greater Glasgow and Clyde · Glasgow · NCT05697159

• Better After Choosing: Filgotinib versus TNF inhibitor options for rheumatoid arthritis

  This trial will test whether letting adults with active rheumatoid arthritis choose between the oral JAK inhibitor filgotinib or a TNF-blocking biologic leads to higher treatment satisfaction compared with being randomly assigned to one of those treatments.

  Recruiting Phase 4 Rheumatology Research Center Northern Netherlands · Leeuwarden · NCT04985435

Quick answers

How many clinical trials of Filgotinib are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 17 countries. The most sites are in United Kingdom (4 trials), France (3 trials), Germany (3 trials), Belgium (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →